Global Liquid Biopsy Market Forecast 2022

1

• Global Liquid Biopsy Market Forecast 2022

2
Summary

• The global liquid biopsy market should reach 4.5
  billion by 2022 from 1.5 billion in 2017 at a
  compound annual growth rate (CAGR) of 24.2, from
  2017 to 2022.
• Report Includes
• An overview of the global markets for liquid
  biopsy research tools, services, and diagnostics
• Analyses of global market trends, with data from
  2015 and 2016, estimates for 2017, and
  projections of compound annual growth rates
  (CAGRs) through 2022
• Coverage of how these technologies can reduce
  invasive tumor biopsies, drive early cancer
  detection, and support precise drug
  administration
• Detailed analysis of liquid biopsy workflow
  technologies, biomarker classes, sample types,
  and research tools reagents

3
(No Transcript)
4
Study Goals and Objectives

• Its goal for this study is to provide an
  in-depth update study of the liquid biopsy
  diagnostics industry, an emerging industry with
  high market potential. The global market is
  analyzed by application, biomarker type, analysis
  platform, analysis purpose and geography. The
  market sizes are given for the years 2015, 2016,
  2017 (estimated) and 2022 (forecasted).
• Market segments that provide exceptional growth
  opportunities include cancer therapy guidance and
  monitoring and organ transplant surveillance.
• The report provides a comprehensive discussion of
  liquid biopsy technologies, clinical
  applications, industry structure, liquid biopsy
  funding initiatives, global markets, patent
  status and companies. The report is designed to
  provide an in-depth analysis of the industry and
  markets and aid companies in their strategic
  planning efforts relating to life science tools
  and diagnostics.

5
Reasons for Doing This Study

• Traditional biopsy methods are often invasive,
  uncomfortable and carry risks of side effects.
  Liquid biopsy addresses these issues because it
  is noninvasive and carries little, if any, side
  effect risks.
• In the age of genomics and personalized medicine,
  it is critical for clinicians to have diagnostic
  tools that can be used on a regular basis to
  screen, monitor, conduct surveillance, guide
  treatment or otherwise give valuable genomic
  information about a disease. Liquid biopsy
  provides this capability and thus is of high
  interest to the medical community.
• Liquid-biopsy-enabling technologies are coming to
  the forefront and provide significant market
  growth momentum to the industry. Downstream
  analysis technologies like next-generation
  sequencing and digital polymerase chain reaction
  (PCR) are progressing in capabilities,
  efficiency, and costs.

6
Related Reports

• MicroRNA Research Tools, Diagnostics and
  Therapeutics Global Markets
• Molecular Diagnostics Technologies and Global
  Markets
• 2017-2022 Global Top Countries Prostate Cancer
  Diagnostics Market Report
• 2017-2022 India Prostate Cancer Diagnostics
  Market Report (Status and Outlook)
• Global Diagnostic Imaging Product Portfolio
  Market Report and Forecast to 2021

7
Full Reports
Global Liquid Biopsy Market Forecast 2022
Contact us atBharat Book Bureau Tel 91 22
27810772 / 27810773 Email poonam_at_bharatbook.com O
ur Blog https//www.bharatbook.com/blog/ Twitter
https//twitter.com/researchbook Facebook
https//www.facebook.com/BharatBook3B LinkedIn
http//www.linkedin.com/company/bharat-book-bureau